|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A01K 67/027 | (2006.01) |
| C07K 16/00 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3046412 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14781761.3 |
| Date of filing the European patent application | 2014-09-18 | |
| (97) | Date of publication of the European application | 2016-07-27 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-10 |
| (46) | Date of publication of the claims translation | 2019-07-25 |
| (86) | Number | PCT/US2014/056285 |
| Date | 2014-09-18 |
| (87) | Number | WO 2015/042250 |
| Date | 2015-03-26 |
| (30) | Number | Date | Country code |
| 201314030424 | 2013-09-18 | US |
| (72) |
MCWHIRTER, John, US
MACDONALD, Lynn, US
MURPHY, Andrew J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Histidino pakeitimus lengvoje grandinėje turintys antikūnai ir genetiškai modifikuoti gyvūnai, išskyrus žmogų, išvesti jų gamybai |
| HISTIDINE ENGINEERED LIGHT CHAIN ANTIBODIES AND GENETICALLY MODIFIED NON-HUMAN ANIMALS FOR GENERATING THE SAME |
| Payment date | Validity (years) | Amount | |
| 2020-08-19 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-09-18 |